Gliosarcoma:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Gliosarcoma Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Gliosarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Gliosarcoma 22
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Gliosarcoma Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Merck & Co., Inc. 31
Clinical Trial Overview of Merck & Co., Inc. 31
Eli Lilly and Company 32
Clinical Trial Overview of Eli Lilly and Company 32
Celldex Therapeutics, Inc. 33
Clinical Trial Overview of Celldex Therapeutics, Inc. 33
Celgene Corporation 34
Clinical Trial Overview of Celgene Corporation 34
MediGene AG 35
Clinical Trial Overview of MediGene AG 35
Exelixis, Inc. 36
Clinical Trial Overview of Exelixis, Inc. 36
DNAtrix, Inc. 37
Clinical Trial Overview of DNAtrix, Inc. 37
Biogen Idec Inc. 38
Clinical Trial Overview of Biogen Idec Inc. 38
Arno Therapeutics, Inc. 39
Clinical Trial Overview of Arno Therapeutics, Inc. 39
Actelion Ltd 40
Clinical Trial Overview of Actelion Ltd 40
Clinical Trial Overview of Top Institutes / Government 41
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
Duke University 45
Clinical Trial Overview of Duke University 45
The University of Texas M. D. Anderson Cancer Center 47
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 47
University of California, San Francisco 48
Clinical Trial Overview of University of California, San Francisco 48
Dana-Farber Cancer Institute, Inc. 49
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 49
Case Comprehensive Cancer Center 50
Clinical Trial Overview of Case Comprehensive Cancer Center 50
City of Hope National Medical Center 51
Clinical Trial Overview of City of Hope National Medical Center 51
UCLA’s Jonsson Comprehensive Cancer Center 52
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 52
Roswell Park Cancer Institute 53
Clinical Trial Overview of Roswell Park Cancer Institute 53
Radiation Therapy Oncology Group 54
Clinical Trial Overview of Radiation Therapy Oncology Group 54
Five Key Clinical Profiles 55
Appendix 128
Abbreviations 128
Definitions 128
Research Methodology 129
Secondary Research 129
About GlobalData 129
Contact Us 129
Disclaimer 130
Source 130


【レポート販売概要】

■ タイトル:Gliosarcoma:グローバル臨床試験レビューH2, 2013
■ 英文:Gliosarcoma Global Clinical Trials Review, H2, 2013
■ 発行日:2013年12月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403163311
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。